JF
FATE icon

Jump Financial’s Fate Therapeutics FATE Stock Holding History

Jump Financial’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-215,600
Closed -$707K – 1788
2024
Q2 		$707K Buy
+215,600
New +$944K 0.01% 972
2023
Q3 		– Sell
-362,053
Closed -$1.72M – 1966
2023
Q2 		$1.72M Buy
362,053
+104,653
+41% +$578K 0.06% 449
2023
Q1 		$1.47M Buy
257,400
+163,911
+175% +$989K 0.06% 461
2022
Q4 		$943K Buy
93,489
+2,979
+3% +$55.9K 0.05% 507
2022
Q3 		$2.03M Sell
90,510
-1,610
-2% -$46.5K 0.08% 379
2022
Q2 		$2.28M Buy
92,120
+45,102
+96% +$1.24M 0.1% 275
2022
Q1 		$1.82M Buy
+47,018
New +$1.82M 0.08% 318
2021
Q4 		– Sell
-30,121
Closed -$1.78M – 1484
2021
Q3 		$1.78M Buy
+30,121
New +$2.36M 0.13% 174

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return